Forget Canopy Growth (TSX:WEED): Why This Pot Stock Could Triple in Value!

Although Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is a good bet to rise in value, this other cannabis stock could be an even better buy today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth (TSX:WEED)(NYSE:CGC) has been on a rough ride this year, falling more than 45% in six months and falling to below $30 a share. While it’s likely attracted the attention of investors thinking that it could be a good buy, whether that’s the case is questionable. Let’s not forget that this is the company that is still looking for a new CEO, is continuing to weigh down Constellation Brands, and that’s still close to a valuation of $10 billion.

Although it has been a big drop for Canopy Growth, the reality is that the stock was grossly overpriced to begin with; it simply wasn’t worth the $20 billion valuation that it reached earlier this year. That being said, the company is going to be a significant player in the edibles market, and that alone could drive a lot of growth and excitement. I wouldn’t be surprised if Canopy Growth is able to get back to $50 or even $60, for that matter. However, a lot would have to go right for the company, and that’s just not a bet I’d make today.

Underrated retail stock could offer more potential

Rather than Canopy Growth, investors may want to take a closer look at Fire and Flower (TSX:FAF). The cannabis retailer is coming off a strong quarter where its revenues reached over $11 million. A year ago, the company wasn’t generating revenues yet, as it was still prior to the launch of the recreational market. But Fire & Flower has been making a name for itself since then, growing its operations in many parts of the country and being a very formidable threat in the industry.

Just this week, Fire & Flower announced that through its subsidiary, it had closed a deal that would see it acquire another eight locations in Alberta. With licences in other key provinces like Saskatchewan, Manitoba, and Ontario, the company is setting itself up for some significant growth, especially once edibles start being sold in stores. In its most recent earnings release, Fire & Flower said that it had 22 retail stores open. With supply issues slowing sorting themselves out, we could see more pot shops opening, and Fire & Flower could be in a great opportunity to take advantage of that.

Key partnership gives the company a big advantage over its peers

While investors may be concerned given the pressure this growth will put on the company’s cash flow, Fire & Flower has a strong investor in Alimentation Couche-Tard that will be able to lean on and to help gain insights from a global company that knows all about expansion. That partnership will give Fire & Flower a big advantage over its rivals, and that’s where the company could be a great buy today. At a market cap of around $130 million heading into trading on Tuesday, Fire & Flower is still a very small stock, but it may not stay that way, as the retail market continues to grow in Canada.

It’s very plausible for the company to triple and get to a valuation of around $400 million. A lot will depend on how the company’s operations go and how much cash it’s bleeding, but things definitely look good for Fire & Flower today, and amid all the selling in the cannabis industry, this could prove to be one of the better buys out there.

Should you invest $1,000 in NorthWest Healthcare Properties right now?

Before you buy stock in NorthWest Healthcare Properties, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and NorthWest Healthcare Properties wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. Couche-Tard is a recommendation of Stock Advisor Canada.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »